Company OptimizeRx Corporation

Equities

OPRX

US68401U2042

Internet Services

Market Closed - Nasdaq 21:00:00 01/05/2024 BST 5-day change 1st Jan Change
10.42 USD +2.16% Intraday chart for OptimizeRx Corporation +13.76% -27.18%

Business Summary

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.

Number of employees: 136

Sales per Business

USD in Million2022Weight2023Weight Delta
Intelligent Technology Platform
100.0 %
62 100.0 % 72 100.0 % +14.53%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
62 100.0 % 72 100.0 % +14.53%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 21/02/16
Director of Finance/CFO 58 10/10/21
President 46 28/04/19
Chief Tech/Sci/R&D Officer 69 31/12/18
Compliance Officer 60 07/02/21
Investor Relations Contact - -
Corporate Officer/Principal - 24/10/23
Human Resources Officer - 30/11/19
Sales & Marketing 58 31/01/08

Members of the board

Members of the board TitleAgeSince
Director/Board Member 65 20/07/20
Director/Board Member 65 01-23
Director/Board Member 68 26/03/18
Chairman 68 23/09/15
Director/Board Member 59 11/01/17
Chief Executive Officer 55 21/02/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,925,311 15,932,174 ( 79.96 %) 1,741,397 ( 8.740 %) 79.96 %

Shareholders

NameEquities%Valuation
First Light Asset Management LLC
9.515 %
1,727,298 9.515 % 21 M $
1,384,467 7.627 % 17 M $
BlackRock Advisors LLC
6.014 %
1,091,642 6.014 % 13 M $
Vanguard Fiduciary Trust Co.
5.625 %
1,021,002 5.625 % 12 M $
Divisadero Street Capital Management LP
5.231 %
949,550 5.231 % 12 M $
AWM Investment Co., Inc.
4.518 %
820,042 4.518 % 10 M $
William Blair & Co. LLC
4.083 %
741,104 4.083 % 9 M $
Will Febbo
2.965 %
538,144 2.965 % 7 M $
Kennedy Capital Management LLC
2.703 %
490,685 2.703 % 6 M $
G2 Investment Partners Management LLC
2.579 %
468,120 2.579 % 6 M $

Company contact information

OptimizeRx Corp.

260 Charles Street Suite 302

02453, Waltham

+

http://www.optimizerx.com
address OptimizeRx Corporation(OPRX)
  1. Stock Market
  2. Equities
  3. OPRX Stock
  4. Company OptimizeRx Corporation